CompaniesByCap
NBIX
Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare

Neurocrine Biosciences Inc. Price to FCF Ratio 2006–2026

Price to free cash flow (P/FCF) ratio for Neurocrine Biosciences Inc. (NBIX): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 18.19.
From: 06/30/2011To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF

Neurocrine Biosciences Inc. Price to FCF Ratio — FAQ

Neurocrine Biosciences Inc. (NBIX) price to fcf ratio over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see NBIX's price to fcf ratio history?

The chart and table above show Neurocrine Biosciences Inc.'s price to fcf ratio by year and by quarter, including the growth rate.